In the 1980s, scientists made a major breakthrough in the field of medical research with the discovery of cannabinoid receptors in our bodies. This discovery led to the identification of the cannabinoid receptor type 1 (CB1) and set the stage for further research on this important system in the human body.
The endocannabinoid system, which contains these receptors, plays a crucial role in regulating various functions in the body, such as mood, pain sensation, appetite, and memory.
In 1990, the DNA sequence that encodes a G-protein-coupled cannabinoid receptor in the human brain was cloned, and three years later, a second brain cannabinoid receptor named cannabinoid receptor type 2 (CB2) was determined.
These receptors are located in different parts of the body and play a vital role in regulating various functions. In this article, we delve into the anatomy of cannabinoid receptors and explore the consequences of impaired cannabinoid receptor function."
Cannabinoid receptors are located in the endocannabinoid system, which is also responsible for producing endocannabinoids inside the body.
CB1 receptors are found in the brain, spinal cord, and other parts of the nervous system. When cannabinoids attach to these receptors, they can influence mood, pain sensation, appetite, and memory.
CB2 receptors are found in certain cells outside of the brain and nervous system. When cannabinoids attach to these receptors, they can influence things like inflammation and pain regulation.
Cannabinoid receptors play an important role in many functions in the body. When cannabinoid receptor function is impaired, symptoms may appear. Diagrams of the anatomy of the cannabinoid receptor show its location and how it functions when healthy and when impaired.
Structure of cannabinoid receptors
Photo by Amel Uzunovic on Pexels
Cannabinoid receptors are located in the endocannabinoid system, which is found in all mammals. This system consists of various receptors that regulate different physiological and metabolic functions. Think of the endocannabinoid system in your body like a control center. It's made up of different receptors that help regulate different things, like how your body feels pain, or how it produces fats.
The two types of cannabinoid receptors: CB1 and CB2. Both are G-protein coupled receptors, meaning that when a cannabinoid molecule attaches to the receptor it triggers a series of events that ultimately results in a physiological response. They are like little buttons that when pushed, start a chain of events in your body that ultimately result in a response. For example, when a substance called a cannabinoid attaches to a receptor, it makes it activate and start the process.
CB1 receptors are found in many parts of the body, including the brain, where they are believed to play a role in communication between nerve cells. CB1 receptors are most abundant in the brain, specifically in the basal ganglia and hippocampus. They also occur in the spinal cord and peripheral tissues like immune cells. They help regulate certain processes by releasing certain substances that change the activity of cells. CB1 receptors are also found in the liver, where they play a role in the production of fats.
CB2 receptors, on the other hand, can be found in various parts of the body, including the immune system (T cells, macrophages, and B cells), blood cells, and brain/central nervous system. . Unlike CB1 receptors, however, they are found mostly on cells outside of the basal ganglia and hippocampus. They are involved in reducing pain and their role in other parts of the body, such as in microglial cells in the brain, is not yet clear. CB2 receptors can affect different types of cells, including immune cells, blood vessel and muscle cells, heart cells, and some nerve cells.
Both types of cannabinoid receptors consist of several protein molecules stacked on top of each other. This allows them to respond to different things and change their shape to do their job.
Types of Cannabinoid Receptors
Photo by Kindel Media on Pexels
The presence of more cannabinoid receptors has been suggested for a long time because of the effects of certain compounds that cause effects similar to cannabinoids but don't activate either CB1 or CB2.Recent studies have shown that the N-arachidonoyl glycine (NAGly) receptor GPR18 may be the receptor for abnormal cannabidiol and that NAGly can cause microglial cells to move in the central nervous system through activation of GPR18.
Okay, so imagine that your brain has tiny doors called receptors. Some of these receptors respond to a chemical called cannabinoids, which are found in cannabis. For a long time, scientists thought that there were only two types of cannabinoid receptors in our brain - CB1 and CB2.
But recently, they found out that there might be more cannabinoid receptors! There might even be two more cannabinoid receptors that haven't been discovered yet! Some studies suggest that there could be a fifth cannabinoid receptor called GPR119 and that certain other types of receptors can also respond to cannabinoids.
When a cannabinoid activates one of these receptors, it can cause different effects. Activating CB1 receptors can affect our mood, memory, appetite, and pain sensation. While activating CB2 receptors mostly affects our immune system.
Studies also suggest that the receptor GPR55 may be a cannabinoid receptor based on its response to cannabinoid ligands. Some experts believe that GPR55 should be categorized as the CB3 receptor.
Interestingly, CBD works through a unique mechanism that does not directly activate either cannabinoid receptor type. Instead, it modulates cell metabolism and reduces activation of these cannabinoid receptors. CBD may indirectly influence these receptors by modulating cell metabolism, but this effect is less direct than direct receptor activation.
Another possible cannabinoid receptor has been found in the hippocampus, but its gene hasn't been cloned yet, which means there may be two more receptors yet to be discovered. Some studies suggest that GPR119 could be a fifth cannabinoid receptor and that the PPAR family of nuclear hormone receptors can respond to some cannabinoids.
How Cannabinoids Signal with the Receptor
Photo by Anna Shvets on Pexels
Cannabinoids interact with the cannabinoid receptors in the endocannabinoid system in various ways. Cannabinoid receptors are found in different parts of the body, including the brain and immune system, and are activated by cannabinoids found naturally in the body or from outside sources like cannabis
Think about the endocannabinoid system in your body like a bunch of locks and keys. The locks are the cannabinoid receptors, and the keys are the cannabinoids. When you put the right key into the lock, it opens up and activates a pathway in your body.
Some cannabinoids, like THC, directly bind to the receptors and turn the lock. Others, like CBD, don't directly bind to the lock, but still have an impact on your body. CBD affects the body by changing the levels of other substances that can bind to the receptors.
The activation of the cannabinoid receptors can have positive effects, but too much exposure to cannabinoids, especially during development, can change how the receptors work and lead to problems like changes in brain development or behavioral issues.
For example, there's a molecule in your body called anandamide, and there's an enzyme that breaks it down. CBD stops this enzyme from working, so the anandamide stays in your body, a naturally occurring endogenous cannabinoid molecule. This increases the level of anandamide in the body, resulting in effects similar to those produced by THC.
CBD also indirectly inhibits the fatty acid amide hydrolase (FAAH) enzyme, which breaks down anandamide. By doing this, CBD allows anandamide to persist in the body for longer, leading to its own set of effects.
When the receptors are activated, it triggers different pathways within the cells. It was originally thought that the receptors mainly affected the production of a molecule called cyclic AMP, but it has since been found to have a much more complex impact on the cells.
Binding to the cannabinoid receptors, such as CB1 and CB2, produces effects in the body, but it can also produce undesirable effects. Prenatal exposure to cannabis can impact the natural signaling system of the body, potentially causing changes in brain development and leading to neurophysiological disorders and behavioral problems.
The Role of the Endocannabinoid System
Photo by MART PRODUCTION on Pexels
The discovery of the CB1R receptor led to the identification of two key endocannabinoids: AEA and 2-AG.
The discovery of a molecule called the CB1R plays a huge role in the body's endocannabinoid system. Also found two main endocannabinoids, AEA and 2-AG, that interact with the CB1R and other receptors in the body. AEA is a high-affinity, partial agonist of the CB1R, while 2-AG acts as a full agonist at both CB1R and CB2R. AEA is degraded by FAAH, while 2-AG is mostly hydrolyzed by MAGL. Both AEA and 2-AG can also be oxidized by different enzymes.
Think of the endocannabinoid system (ECS) as a control center in your body that helps regulate how you feel and function. Scientists have discovered two key parts of this system, called endocannabinoids, which are AEA and 2-AG. These endocannabinoids work with special receptors, like CB1R, to control things like your mood, hunger, memory, pain, sleep, and more.
AEA and 2-AG are two types of chemical compounds that exist naturally in our bodies. They interact with two types of receptors called CB1R and CB2R, and they are produced when there is an increased amount of calcium in our bodies.
AEA is a partial agonist at CB1R, which means it doesn't work as well as a full agonist, but still has a high affinity for the receptor. On the other hand, 2-AG is a full agonist at both CB1R and CB2R, meaning it works well at both receptors.
Both AEA and 2-AG are created from different things and are transported and broken down in different ways. Some enzymes can also help break them down, including FAAH and MAGL.
In short, AEA and 2-AG are important chemicals in our bodies that help regulate things like mood, appetite, memory, pain perception, fertility, sleep, and more.
The function of the ECS is influenced by the specific receptors that are activated, the endocannabinoids involved, and the location in the body where the activation occurs.
The effects of cannabinoids on the receptor
Once a cannabinoid molecule interacts with a cannabinoid receptor, it can either activate or inhibit it. When a cannabinoid activates a receptor, it acts as a ligand, a substance that binds to a membrane-bound protein, and binds to the receptor.
The CB1R and CB2R are two types of receptors that are part of a family of proteins called GPCR.
These receptors help control the activity of other proteins in the body. The CB1R has been shown to activate other G proteins in some circumstances, and can also affect the activity of certain ion channels and the activity of other signaling pathways.
The CB1R can also signal in a G protein-independent manner through association with other molecules such as β-arrestin, which is a key mediator of GPCR desensitization. The CB1R's activity can be regulated by β-arrestin in a ligand-specific manner. Studies using β-arrestin knockout mice have suggested a critical role of β-arrestin in regulating CB1R activity.
So, you know how when you eat chocolate and it makes you feel happy or relaxed? That's kind of like what happens in your body when you use cannabis. There are special proteins in your body called receptors that can be activated by different substances, like THC and CBD, which are found in cannabis.
When a substance like THC binds to one of these receptors, called CB1R, it activates the receptor and changes the way other proteins in your body work. THC has a strong binding affinity, which means it binds really well to the receptor, so it makes the receptor activate more strongly.
CBD is different because it has a weaker binding affinity, so it doesn't activate the receptors as strongly as THC does. Sometimes, when a substance binds too strongly to the receptor, it can actually prevent the receptor from being activated at all. This is called inhibition.
Activation of the receptors can occur through different mechanisms, including G-protein coupling or the direct activation of ion channels. These mechanisms lead to changes in the levels of calcium and sodium ions in cells, resulting in alterations in cell function.
Inhibition of the receptor occurs when the binding between the cannabinoid and the receptor is strong, preventing activation of the receptor.
So, when you use cannabis, it's kind of like you're giving your body different instructions on how to work. The receptors help control the activity of other proteins in your body and THC's strong binding to the receptors can cause changes in the levels of certain ions in your cells, which can lead to changes in cell function.
Medical uses of Cannabinoids
Medical applications of cannabinoids are perhaps the strongest motivating factor for the legalization movement. Many people have testified to the healing properties of cannabis, and national health organizations around the world have funded extensive research on the drug.
Cannabinoids have shown promising results in treating a variety of medical conditions, including cancer, neurological disorders such as multiple sclerosis and Parkinson's disease, neuropathic pain, obesity, diabetes, hypertension, insomnia, anxiety and depression, and immune system disorders. The CB1R is a special protein that is found all over the human body and it helps regulate various functions such as appetite, memory, mood, and movement. It also helps with some medical conditions like pain, glaucoma, and epilepsy. This protein can also protect the brain from damage by controlling the amount of certain chemicals in the brain.
Scientists have found that the CB1R can help with some brain diseases like Alzheimer's, Parkinson's, and Huntington's. For example, in Parkinson's disease, in some cases the CB1R has been found to be upregulated, which means that it is more active in the brain. This can help to compensate for the degeneration of other brain cells, but in some cases it may also contribute to the worsening of the disease. In other cases, the CB1R has been found to be downregulated, which means that it is less active. In these cases, activating the CB1R has been shown to be beneficial in improving memory and cognitive function in Alzheimer's patients and reducing the symptoms of Parkinson's disease.
The CB1R can also help the body regulate the effects of epilepsy. This receptor can be activated by a type of molecule called AEA, which can help to reduce seizures. However, activation of the CB1R by marijuana can sometimes have the opposite effect and increase the frequency of seizures. The effects of the CB1R on epilepsy are complex and depend on various factors, such as the type of cell in the body and the stage of epilepsy. In some cases, the CB1R is downregulated in the early stages of epilepsy, but upregulated in the later stages.
Research has also shown that some cannabinoids can directly or indirectly affect cancer cells, such as by inhibiting their growth or causing them to die (apoptosis). However, the exact role of the endocannabinoid system in cancer is still not fully understood and is the subject of ongoing research. Some studies have found that an overactive endocannabinoid system can actually promote cancer growth, while others have found that it can help suppress it. It's also possible that the effects of cannabinoids on cancer cells can vary depending on the concentration used. When it comes to cancer, the CB1R and other parts of the endocannabinoid system play a role in helping control some of the side effects of cancer and cancer treatments, like reducing nausea and vomiting, relieving pain, and increasing appetite.
CBD, in particular, has been extensively studied for its medical applications and has shown promising results in the treatment of various conditions. For example, a 2016 pilot study conducted by the National Center for Biotechnology Information (NCBI) found that CBD administration was associated with significant reductions in alcohol consumption, suggesting its potential use in treating alcoholism. The National Institute on Drug Abuse (NIDA) in the United States has funded research into the therapeutic effects of CBD on neuropathic pain due to spinal cord injury or multiple sclerosis. In addition, many other national health agencies around the world have also funded research into the therapeutic effects of cannabinoids.
Dangers of cannabinoids
While some studies show the potential benefits of cannabinoids, other studies show the potential dangers of cannabinoids. Most of these studies are done on mice or cell cultures, but there have been some research on humans.
Some people who use cannabis may experience nausea and vomiting, loss of appetite, depression, anxiety, insomnia, carb cravings, and lowered libido. While some of these symptoms are experienced by only a small percentage of users, it is possible that cannabis can trigger these symptoms in some people.
The goal is to find cannabinoids that have the therapeutic benefits but not the side effects. One way to achieve this is by adding CBD to the THC, which helps prevent the side effects. Another way is to use other non-psychoactive cannabinoids as the base, which are safer. There is also research being done to find compounds that can modify the effects of CB1R agonists/antagonists and minimize the side effects.
The endocannabinoid system has other elements that can also be targeted for cannabinoid discovery too. There are inhibitors of enzymes that break down endocannabinoids, which can enhance the effects of CB1R. CB2R, another part of the endocannabinoid system, is also gaining interest because it has been shown to have beneficial effects in various conditions. It is also present in the central nervous system, which opens up more therapeutic potential.
However, more research needs to be done to determine how serious these effects are and whether or not people can use cannabinoids without experiencing these side effects.
Conclusion
Photo by RODNAE Productions on Pexels
The endocannabinoid system is a very important part of our bodies that helps control many different things. There are special cannabinoids, like THC, THCa, CBD, CBG, CBA and other chemical compounds bind to these receptors to produce physiological changes in the body and can have a big effect on how we feel and think but , it can also cause some problems if we use drugs that target it.
Receptors can be activated or inhibited by other chemicals and molecules. How they act depends on the level of stimulation they receive. This is why there are both THC and CBD oils- each stimulate different receptors.
Scientists have been studying it for the last 30 years and have found out a lot about it. So, researchers are now looking at other parts of the endocannabinoid system that might be more helpful and have fewer side effects.
Research is continuing into how cannabinoid receptors work and how they can be used to treat various conditions. Already, studies have shown great results for the treatment of nausea, pain, cancer, and other chronic conditions.
Overall, the endocannabinoid system is very complicated and there is still a lot to learn about it. Scientists need to keep studying it in different ways and in different parts of the body to really understand how it works.